Physical & emotional impairments common, often untreated in people with cancer

May 17, 2013

ATLANTA - May 17, 2013- A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D., associate professor at Harvard Medical School, and colleagues say a majority of cancer survivors will have significant physical and psychological impairments as a result of treatments, and that these often go undetected and/or untreated, resulting in disability.

Current data shows more than four in ten people will develop cancer during their lifetime. Due to advances in diagnosis, treatment, and supportive care for cancer, more than two out of three cancer patients now live at least 5 years after diagnosis. The American Cancer Society estimates that the number of cancer survivors in the United States will increase from 13.6 million to 18 million by 2022. However, increased survival brings with it a growing need to address the long-term effects of cancer and its treatment. Cancer survivors report a much worse health-related quality of life for both physical and emotional health compared with population norms.

The review outlines data showing poor physical health is reported by one in four cancer survivors, compared to about one in ten of those without a history of cancer. Meanwhile, poor mental health is reported by ten percent of cancer survivors compared with six percent of adults without a cancer diagnosis. Those numbers suggest that 3.3 million cancer survivors in the United States may have poor physical health and 1.4 million may have poor mental health. The authors say physical and psychological impairments often overlap and influence each other, and a leading cause of emotional distress in cancer survivors is physical disability.

Studies show multidisciplinary cancer rehabilitation, which involves a team of rehabilitation professionals that typically includes physiatrists, physical therapists, occupational therapists, speech-language pathologists, and rehabilitation nurses, improves pain control, physical function, and quality of life in cancer survivors. The authors say "prehabilitation," the precursor to rehabilitation, is recommended at the time of diagnosis, up until treatment begins. The goal of prehabilitation is to improve both physical and emotional health prior to cancer therapy so that people tolerate treatments with fewer problems.

The authors say it is critical that survivors are screened for both psychological and physical impairments and then referred appropriately to trained health care professionals, including rehabilitation specialists, for evaluation and treatment. To ensure all cancer patients have their rehabilitation needs met, everyone involved throughout their care - oncologists, mental health professionals, nurses and primary care physicians-- should have knowledge of the proper screening questions, tools, and procedures. Impairment-driven cancer rehabilitation appears to be cost-effective and may actually reduce both direct and indirect health care costs, and reduce the enormous financial burden of cancer.

The authors conclude: "Delivering quality, patient-centered care requires that all cancer patients and survivors be screened for psychological and physical impairments throughout the care continuum in order to preserve and/or improve their functioning and quality of life."
-end-
Article: Impairment-Driven Cancer Rehabilitation: An Essential Component of Quality Care and Survivorship; Julie K. Silver; Jennifer Baima; R. Samuel Mayer. CA Cancer J Clin 2013; doi: 10.1002/caac.21186.

American Cancer Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.